FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/7/2026
Valeant Pharma (NYSE: VRX) is adding to early gains on a vague rumor Carl Icahn could become involved in the name. Shares are up 3.1%.
For what its worth, Icahn rumors are almost 100% wrong and the last thing the stock needs is another hedge fund manger involved.
... More
